These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 39495)

  • 1. Survival of coxsackievirus B3 under diverse environmental conditions.
    McGeady ML; Siak JS; Crowell RL
    Appl Environ Microbiol; 1979 May; 37(5):972-7. PubMed ID: 39495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of human rhinovirus infectivity under diverse environmental conditions.
    Reagan KJ; McGeady ML; Crowell RL
    Appl Environ Microbiol; 1981 Mar; 41(3):618-20. PubMed ID: 6261689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probable intrafamilial transmission of coxsackievirus b3 with vertical transmission, severe early-onset neonatal hepatitis, and prolonged viral RNA shedding.
    Cheng LL; Ng PC; Chan PK; Wong HL; Cheng FW; Tang JW
    Pediatrics; 2006 Sep; 118(3):e929-33. PubMed ID: 16908622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enterovirus inactivation in soil.
    Yeager JG; O'Brien RT
    Appl Environ Microbiol; 1979 Oct; 38(4):694-701. PubMed ID: 44178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability in the integrity of human enteroviruses exposed to various simulated in vivo environments.
    Piirainen L; Hovi T; Roivainen M
    Microb Pathog; 1998 Sep; 25(3):131-7. PubMed ID: 9790872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albumin Enhances the Rate at Which Coxsackievirus B3 Strain 28 Converts to A-Particles.
    Carson SD; Cole AJ
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31915275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three capsid amino acids notably influence coxsackie B3 virus stability.
    Carson SD; Tracy S; Kaczmarek ZG; Alhazmi A; Chapman NM
    J Gen Virol; 2016 Jan; 97(1):60-68. PubMed ID: 26489722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Kidnapping Story: How Coxsackievirus B3 and Its Host Cell Interact.
    Peischard S; Ho HT; Theiss C; Strutz-Seebohm N; Seebohm G
    Cell Physiol Biochem; 2019; 53(1):121-140. PubMed ID: 31230428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Search for Coxsackievirus B3 RNA in idiopathic dilated cardiomyopathy using gene amplification by polymerase chain reaction.
    Grasso M; Arbustini E; Silini E; Diegoli M; Percivalle E; Ratti G; Bramerio M; Gavazzi A; Vigano M; Milanesi G
    Am J Cardiol; 1992 Mar; 69(6):658-64. PubMed ID: 1311139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxymatrine provides protection against Coxsackievirus B3-induced myocarditis in BALB/c mice.
    Jiang Y; Zhu Y; Mu Q; Luo H; Zhi Y; Shen X
    Antiviral Res; 2017 May; 141():133-139. PubMed ID: 28115196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination treatment with ribavirin and interferon for coxsackievirus B3 replication.
    Okada I; Matsumori A; Matoba Y; Tominaga M; Yamada T; Kawai C
    J Lab Clin Med; 1992 Oct; 120(4):569-73. PubMed ID: 1328433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coxsackievirus B3 infection induced viral myocarditis by regulating the expression pattern of chemokines in cardiac myocytes.
    Shen Y; Kan QC; Xu W; Chu YW; Xiong SD
    Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):1-9. PubMed ID: 19279353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coxsackievirus B3 replication and persistence in intestinal cells from mice infected orally and in the human CaCo-2 cell line.
    Harrath R; Bourlet T; Delézay O; Douche-Aourik F; Omar S; Aouni M; Pozzetto B
    J Med Virol; 2004 Oct; 74(2):283-90. PubMed ID: 15332278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cleavage of Grb2-Associated Binding Protein 2 by Viral Proteinase 2A during
    Deng H; Fung G; Qiu Y; Wang C; Zhang J; Jin ZG; Luo H
    Front Cell Infect Microbiol; 2017; 7():85. PubMed ID: 28361043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilization of "A" particles of coxsackievirus B3 by a HeLa cell plasma membrane extract.
    McGeady ML; Crowell RL
    J Virol; 1979 Dec; 32(3):790-5. PubMed ID: 513203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
    Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Consequences of RNA 5'-Terminal Deletions on Coxsackievirus B3 RNA Replication and Ribonucleoprotein Complex Formation.
    Lévêque N; Garcia M; Bouin A; Nguyen JHC; Tran GP; Andreoletti L; Semler BL
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28539455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide and murine coxsackievirus B3 myocarditis: aggravation of myocarditis by inhibition of nitric oxide synthase.
    Hiraoka Y; Kishimoto C; Takada H; Nakamura M; Kurokawa M; Ochiai H; Shiraki K
    J Am Coll Cardiol; 1996 Nov; 28(6):1610-5. PubMed ID: 8917278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acid stability of hepatitis A virus.
    Scholz E; Heinricy U; Flehmig B
    J Gen Virol; 1989 Sep; 70 ( Pt 9)():2481-5. PubMed ID: 2550575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary characterization of coxsackievirus B3 temperature-sensitive mutants.
    Gauntt CJ; Trousdale MD; Lee JC; Paque RE
    J Virol; 1983 Mar; 45(3):1037-47. PubMed ID: 6300445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.